October 19, 2020
Health News

Rapid research in a deadly epidemic pays off – The Verge

Filed under:
Antivirus: A weekly digest of COVID-19 research
Image: CDC
This weeks US Food and Drug Administration approval of an Ebola drug is a big milestone in drug development one thats closely tied to our current efforts to fight COVID-19.
Before COVID-19 started sweeping across the world, Ebola was one of the most high-profile viral diseases on the planet. Everyone was ready to speed up and contribute and do things with Ebola that they dont routinely do because Ebola is such a dire si…

Click here to view the original article.

Related Posts

You might also like ...

post featured image
Brain-Injured Man Temporarily Regains Ability to Talk and Walk After Taking Ambien – Gizmodo
post featured image
COVID-19’s Impact on the Heart – An In-Depth Look – SciTechDaily
post featured image
Doctors May Have Found Secretive New Organs in the Center of Your Head – The New York Times